JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cellsShuhei Suzuki, Chifumi Kitanaka|Oncotarget|2014Cited by 94
Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cellsShuhei Suzuki, Chifumi Kitanaka|Oncotarget|2018Cited by 56
<i>In vitro</i>and<i>in vivo</i>anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profileShuhei Suzuki, Masashi Okada|Oncotarget|2019Cited by 23
Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug RepurposingShuhei Suzuki, Chifumi Kitanaka|Biomedicines|2020Cited by 21
Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 ReductionShuhei Suzuki, Chifumi Kitanaka|Life|2021Cited by 15